Achieve Life Sciences, Inc.
NASDAQ:ACHVBiotechnology
-$0.38 today
- Market cap
- $697.68M
- Beta
- 2.26
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$0.97
Volume 1.09M
Average 1.44M
ACHV Common Stock Repurchased
Cash spent buying back the company's own shares.
Achieve Life Sciences, Inc.NASDAQ: ACHV
Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026
Common stock repurchased outflow grows to $0
Q1 FY2026 common stock repurchased was $0, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was $0.
Context
- Common stock repurchased increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock repurchased holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | +100.0% |
| FY2023 | 2023-12-31 | (30K) | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Repurchased vs competitors
How ACHV compares with its peers on the latest reported figures
No competitor Common Stock Repurchased figures are available to compare.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (33.15M) | (42.35M) | (29.82M) | (39.83M) | (54.65M) |
| Depreciation & Amortization | 250K | 236K | 228K | 229K | 228K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.19M | 3.27M | 3.44M | 5.33M | 8.76M |
| Change in Working Capital | 1.23M | 79K | (778K) | 2.41M | (4.27M) |
| Accounts Receivables | (153K) | 48K | 0 | 111K | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 509K | 799K | (1.04M) | 1.33M | (1.08M) |
| Other Working Capital | 878K | (768K) | 264K | 969K | (3.18M) |
| Other Non-Cash Items | 41K | 1.2M | 2.45M | 2.09M | 460K |
| Operating Cash Flow | (29.44M) | (37.57M) | (24.48M) | (29.77M) | (49.47M) |
| Capital Expenditures | 0 | 0 | (21K) | 0 | (3K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (47.89M) | (24.76M) |
| Sales of Investments | 0 | 0 | 0 | 26.31M | 30.87M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 3K |
| Investing Cash Flow | 0 | 0 | (21K) | (21.58M) | 6.11M |
| Debt Repayment | 14.93M | 0 | 0 | (8.3M) | 5M |
| Common Stock Issued | 21.34M | 19.21M | 15.3M | 56.08M | 46.53M |
| Common Stock Repurchased | 0 | 0 | (30K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 338K | 103K | 7K | 746K | 0 |
| Financing Cash Flow | 36.61M | 19.32M | 15.28M | 48.53M | 51.53M |
| Effect of Forex Changes | (1K) | 3K | (3K) | 30K | 3K |
| Net Change in Cash | 7.17M | (18.25M) | (9.23M) | (2.79M) | 8.18M |
| Free Cash Flow | (29.44M) | (37.57M) | (24.5M) | (29.77M) | (49.47M) |
Achieve Life Sciences, Inc.
NASDAQ:ACHV
Intrinsic Alpha fair value
Locked
Current Price
$6.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.